MY ACCOUNT | NEWSLETTER |

Ultrasonographic features of gastric mucosal hypertrophy in dogs receiving chronic omeprazole a retrospective case series.

Clinical evidence update from Journal of the American Veterinary Medical Association


Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of the American Veterinary Medical Association in 2026 evaluated ultrasonographic features of gastric mucosal hypertrophy in dogs receiving chronic omeprazole: a retrospective case series..

Key Findings

To describe ultrasonographic features of gastric mucosal abnormalities in dogs receiving chronic omeprazole therapy. Medical records from a veterinary teaching hospital were retrospectively reviewed to identify dogs evaluated between 2020 and 2026 with a history of chronic (≥ 5 months) omeprazole administration that had undergone abdominal ultrasonography. Dogs were included if ultrasonography demonstrated gastric wall abnormalities consistent with a defined pattern. Nine dogs met the inclusion criteria. Dogs were medium to large breed and receiving omeprazole for management of portosystemic shunting, gastric ulceration, or chronic...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

After medical testing at OSU veterinary hospital, Oregon Zoo tiger Bernadette happy & healthy

Like0
Dislike0

Antech™ Expands trūRapid™ FOUR and trūRapid™ FIV/FeLV Rapid Tests to Canada After CFIA Approval

Like0
Dislike0

Endocrine diseases in Brazilian small-animal hospitals and referral caseloads A systematic review and meta-analysis of proportions.

Like0
Dislike0

Mapping Variability in Bovine Respiratory Disease Risk Factors in Beef Production Systems A Scoping Review.

Like0
Dislike0

New World Screwworm Q&A with Dr. Isabelle Louge

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top